These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

400 related items for PubMed ID: 15986461

  • 1. Intracellular delivery of doxorubicin with RGD-modified sterically stabilized liposomes for an improved antitumor efficacy: in vitro and in vivo.
    Xiong XB, Huang Y, Lu WL, Zhang X, Zhang H, Nagai T, Zhang Q.
    J Pharm Sci; 2005 Aug; 94(8):1782-93. PubMed ID: 15986461
    [Abstract] [Full Text] [Related]

  • 2. Enhanced intracellular delivery and improved antitumor efficacy of doxorubicin by sterically stabilized liposomes modified with a synthetic RGD mimetic.
    Xiong XB, Huang Y, Lu WL, Zhang X, Zhang H, Nagai T, Zhang Q.
    J Control Release; 2005 Oct 03; 107(2):262-75. PubMed ID: 16125816
    [Abstract] [Full Text] [Related]

  • 3. Enhanced intracellular uptake of sterically stabilized liposomal Doxorubicin in vitro resulting in improved antitumor activity in vivo.
    Xiong XB, Huang Y, Lu WL, Zhang H, Zhang X, Zhang Q.
    Pharm Res; 2005 Jun 03; 22(6):933-9. PubMed ID: 15948037
    [Abstract] [Full Text] [Related]

  • 4. A comprehensive study of iRGD-modified liposomes with improved chemotherapeutic efficacy on B16 melanoma.
    Dai W, Fan Y, Zhang H, Wang X, Zhang Q, Wang X.
    Drug Deliv; 2015 Jan 03; 22(1):10-20. PubMed ID: 24735248
    [Abstract] [Full Text] [Related]

  • 5. [Cellular toxicity and anti-tumor efficacy of iRGD modified doxorubixin loaded sterically stabilized liposomes].
    Zhao B, Fan YC, Wang XQ, Dai WB, Zhang Q, Wang XL.
    Yao Xue Xue Bao; 2013 Mar 03; 48(3):417-22. PubMed ID: 23724658
    [Abstract] [Full Text] [Related]

  • 6. The antitumor activity of a doxorubicin loaded, iRGD-modified sterically-stabilized liposome on B16-F10 melanoma cells: in vitro and in vivo evaluation.
    Yu KF, Zhang WQ, Luo LM, Song P, Li D, Du R, Ren W, Huang D, Lu WL, Zhang X, Zhang Q.
    Int J Nanomedicine; 2013 Mar 03; 8():2473-85. PubMed ID: 23885174
    [Abstract] [Full Text] [Related]

  • 7. A novel octreotide modified lipid vesicle improved the anticancer efficacy of doxorubicin in somatostatin receptor 2 positive tumor models.
    Zhang J, Jin W, Wang X, Wang J, Zhang X, Zhang Q.
    Mol Pharm; 2010 Aug 02; 7(4):1159-68. PubMed ID: 20524673
    [Abstract] [Full Text] [Related]

  • 8. Targeted delivery of RGD-modified liposomes encapsulating both combretastatin A-4 and doxorubicin for tumor therapy: in vitro and in vivo studies.
    Zhang YF, Wang JC, Bian DY, Zhang X, Zhang Q.
    Eur J Pharm Biopharm; 2010 Mar 02; 74(3):467-73. PubMed ID: 20064608
    [Abstract] [Full Text] [Related]

  • 9. Enhanced Specificity and Drug Delivery in Tumors by cRGD-Anchoring Thermosensitive Liposomes.
    Dicheva BM, ten Hagen TL, Seynhaeve AL, Amin M, Eggermont AM, Koning GA.
    Pharm Res; 2015 Dec 02; 32(12):3862-76. PubMed ID: 26202516
    [Abstract] [Full Text] [Related]

  • 10. Disaccharide-modified liposomes and their in vitro intracellular uptake.
    Song CK, Jung SH, Kim DD, Jeong KS, Shin BC, Seong H.
    Int J Pharm; 2009 Oct 01; 380(1-2):161-9. PubMed ID: 19635539
    [Abstract] [Full Text] [Related]

  • 11. [Preparation of doxorubicin-loaded stealth liposomes modified with RGD mimetic and cellular association in vitro].
    Xiong XB, Huang Y, Lü WL, Zhang X, Zhang H, Zhang Q.
    Yao Xue Xue Bao; 2005 Dec 01; 40(12):1085-90. PubMed ID: 16496670
    [Abstract] [Full Text] [Related]

  • 12. Development of a novel cyclic RGD peptide for multiple targeting approaches of liposomes to tumor region.
    Amin M, Mansourian M, Koning GA, Badiee A, Jaafari MR, Ten Hagen TLM.
    J Control Release; 2015 Dec 28; 220(Pt A):308-315. PubMed ID: 26526970
    [Abstract] [Full Text] [Related]

  • 13. Sequential treatment of drug-resistant tumors with RGD-modified liposomes containing siRNA or doxorubicin.
    Jiang J, Yang SJ, Wang JC, Yang LJ, Xu ZZ, Yang T, Liu XY, Zhang Q.
    Eur J Pharm Biopharm; 2010 Oct 28; 76(2):170-8. PubMed ID: 20600887
    [Abstract] [Full Text] [Related]

  • 14. Enhanced circulation time and antitumor activity of doxorubicin by comblike polymer-incorporated liposomes.
    Han HD, Lee A, Hwang T, Song CK, Seong H, Hyun J, Shin BC.
    J Control Release; 2007 Jul 31; 120(3):161-8. PubMed ID: 17524514
    [Abstract] [Full Text] [Related]

  • 15. Targeted delivery of doxorubicin via sterically stabilized immunoliposomes: pharmacokinetics and biodistribution in tumor-bearing mice.
    Emanuel N, Kedar E, Bolotin EM, Smorodinsky NI, Barenholz Y.
    Pharm Res; 1996 Jun 31; 13(6):861-8. PubMed ID: 8792423
    [Abstract] [Full Text] [Related]

  • 16. RGD-based strategies for improving antitumor activity of paclitaxel-loaded liposomes in nude mice xenografted with human ovarian cancer.
    Zhao H, Wang JC, Sun QS, Luo CL, Zhang Q.
    J Drug Target; 2009 Jan 31; 17(1):10-8. PubMed ID: 19016068
    [Abstract] [Full Text] [Related]

  • 17. Targeted treatment of choroidal neovascularization using integrin-mediated sterically stabilized liposomes loaded with combretastatin A4.
    Ma L, Liu YL, Ma ZZ, Dou HL, Xu JH, Wang JC, Zhang X, Zhang Q.
    J Ocul Pharmacol Ther; 2009 Jun 31; 25(3):195-200. PubMed ID: 19456253
    [Abstract] [Full Text] [Related]

  • 18. iNGR-Modified Liposomes for Tumor Vascular Targeting and Tumor Tissue Penetrating Delivery in the Treatment of Glioblastoma.
    Zhou JE, Yu J, Gao L, Sun L, Peng T, Wang J, Zhu J, Lu W, Zhang L, Yan Z, Yu L.
    Mol Pharm; 2017 May 01; 14(5):1811-1820. PubMed ID: 28388081
    [Abstract] [Full Text] [Related]

  • 19. Polyethylene glycol-complexed cationic liposome for enhanced cellular uptake and anticancer activity.
    Jung SH, Jung SH, Seong H, Cho SH, Jeong KS, Shin BC.
    Int J Pharm; 2009 Dec 01; 382(1-2):254-61. PubMed ID: 19666094
    [Abstract] [Full Text] [Related]

  • 20. Improved tumor-targeting drug delivery and therapeutic efficacy by cationic liposome modified with truncated bFGF peptide.
    Chen X, Wang X, Wang Y, Yang L, Hu J, Xiao W, Fu A, Cai L, Li X, Ye X, Liu Y, Wu W, Shao X, Mao Y, Wei Y, Chen L.
    J Control Release; 2010 Jul 01; 145(1):17-25. PubMed ID: 20307599
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.